SEARCH

SEARCH BY CITATION

References

  • 1
    Kleihues P,Louis DN,Scheithauer BW,Rorke LB,Reifenberger G,Burger PCCavenee WK. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002; 61: 21525; discussion 226–9.
  • 2
    von Deimling A,Louis DN,Schramm J,Wiestler OD. Astrocytic gliomas: characterization on a molecular genetic basis. Recent Results Cancer Res 1994; 135: 3342.
  • 3
    Korshunov A,Sycheva R,Golanov A. The prognostic relevance of molecular alterations in glioblastomas for patients age <50 years. Cancer 2005; 104: 82532.
  • 4
    von Deimling A,Louis DN,Wiestler OD. Molecular pathways in the formation of gliomas. Glia 1995; 15: 32838.
  • 5
    Brentani H,Caballero OL,Camargo AA,da Silva AM,da Silva WA,Jr,Dias Neto E,Grivet M,Gruber A,Guimaraes PE,Hide W,Iseli C,Jongeneel CV, et al. The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc Natl Acad Sci USA 2003; 100: 1341823.
  • 6
    Velculescu VE,Zhang L,Vogelstein B,Kinzler KW. Serial analysis of gene expression. Science 1995; 270: 4847.
  • 7
    Jongeneel CV,Iseli C,Stevenson BJ,Riggins GJ,Lal A,Mackay A,Harris RA,O'Hare MJ,Neville AM,Simpson AJ,Strausberg RL. Comprehensive sampling of gene expression in human cell lines with massively parallel signature sequencing. Proc Natl Acad Sci USA 2003; 100: 47025.
  • 8
    Grigoriadis A,Mackay A,Reis-Filho JS,Steele D,Iseli C,Stevenson BJ,Jongeneel CV,Valgeirsson H,Fenwick K,Iravani M,Leao M,Simpson AJ, et al. Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data. Breast Cancer Res 2006; 8: R56.
  • 9
    Gray D,Jubb AM,Hogue D,Dowd P,Kljavin N,Yi S,Bai W,Frantz G,Zhang Z,Koeppen H,de Sauvage FJ,Davis DP. Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers. Cancer Res 2005; 65: 975161.
  • 10
    Nakano I,Paucar AA,Bajpai R,Dougherty JD,Zewail A,Kelly TK,Kim KJ,Ou J,Groszer M,Imura T,Freije WA,Nelson SF, et al. Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation. J Cell Biol 2005; 170: 41327.
  • 11
    Oba-Shinjo SM,Bengtson MH,Winnischofer SM,Colin C,Vedoy CG,de Mendonca Z,Marie SK,Sogayar MC. Identification of novel differentially expressed genes in human astrocytomas by cDNA representational difference analysis. Brain Res Mol Brain Res 2005; 140: 2533.
  • 12
    Cavalieri D,De Filippo C. Bioinformatic methods for integrating whole-genome expression results into cellular networks. Drug Discov Today 2005; 10: 72734.
  • 13
    Livak KJ,Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 4028.
  • 14
    Jeronimo C,Usadel H,Henrique R,Silva C,Oliveira J,Lopes C,Sidransky D. Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer. Urology 2002; 60: 11315.
  • 15
    Horvath S,Zhang B,Carlson M,Lu KV,Zhu S,Felciano RM,Laurance MF,Zhao W,Qi S,Chen Z,Lee Y,Scheck AC, et al. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci USA 2006; 103: 174027.
  • 16
    Rhodes DR,Yu J,Shanker K,Deshpande N,Varambally R,Ghosh D,Barrette T,Pandey A,Chinnaiyan AM. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 2004; 101: 930914.
  • 17
    Rickman DS,Bobek MP,Misek DE,Kuick R,Blaivas M,Kurnit DM,Taylor J,Hanash SM. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res 2001; 61: 688591.
  • 18
    Khatua S,Peterson KM,Brown KM,Lawlor C,Santi MR,LaFleur B,Dressman D,Stephan DA,MacDonald TJ. Overexpression of the EGFR/FKBP12/HIF-2α pathway identified in childhood astrocytomas by angiogenesis gene profiling. Cancer Res 2003; 63: 186570.
  • 19
    Colin C,Baeza N,Bartoli C,Fina F,Eudes N,Nanni I,Martin PM,Ouafik L,Figarella-Branger D. Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using suppression subtractive hybridization. Oncogene 2006; 25: 281826.
  • 20
    van den Boom J,Wolter M,Kuick R,Misek DE,Youkilis AS,Wechsler DS,Sommer C,Reifenberger G,Hanash SM. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 2003; 163: 103343.
  • 21
    Sallinen SL,Sallinen PK,Haapasalo HK,Helin HJ,Helen PT,Schraml P,Kallioniemi OP,Kononen J. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res 2000; 60: 661722.
  • 22
    Gutmann DH,Hedrick NM,Li J,Nagarajan R,Perry A,Watson MA. Comparative gene expression profile analysis of neurofibromatosis 1-associated and sporadic pilocytic astrocytomas. Cancer Res 2002; 62: 208591.
  • 23
    Mischel PS,Cloughesy TF,Nelson SF. DNA-microarray analysis of brain cancer: molecular classification for therapy. Nat Rev Neurosci 2004; 5: 78292.
  • 24
    Tso CL,Freije WA,Day A,Chen Z,Merriman B,Perlina A,Lee Y,Dia EQ,Yoshimoto K,Mischel PS,Liau LM,Cloughesy TF, et al. Distinct transcription profiles of primary and secondary glioblastoma subgroups. Cancer Res 2006; 66: 15967.
  • 25
    Liu H,Jacobs BS,Liu J,Prayson RA,Estes ML,Barnett GH,Barna BP. Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma. Cancer Immunol Immunother 2000; 49: 31924.
  • 26
    Kelly-Welch AE,Hanson EM,Boothby MR,Keegan AD. Interleukin-4 and interleukin-13 signaling connections maps. Science 2003; 300: 15278.
  • 27
    Kawakami M,Leland P,Kawakami K,Puri RK. Mutation and functional analysis of IL-13 receptors in human malignant glioma cells. Oncol Res 2001; 12: 45967.
  • 28
    Mintz A,Gibo DM,Madhankumar AB,Debinski W. Molecular targeting with recombinant cytotoxins of interleukin-13 receptor α2-expressing glioma. J Neurooncol 2003; 64: 11723.
  • 29
    Husain SR,Puri RK. Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside. J Neurooncol 2003; 65: 3748.
  • 30
    Abdel-Fattah R,Xiao A,Bomgardner D,Pease CS,Lopes MB,Hussaini IM. Differential expression of HOX genes in neoplastic and non-neoplastic human astrocytes. J Pathol 2006; 209: 1524.
  • 31
    Simeone A,Acampora D,D'Esposito M,Faiella A,Pannese M,Scotto L,Montanucci M,D'Alessandro G,Mavilio F,Boncinelli E. Posttranscriptional control of human homeobox gene expression in induced NTERA-2 embryonal carcinoma cells. Mol Reprod Dev 1989; 1: 10715.
  • 32
    Maroulakou IG,Spyropoulos DD. The study of HOX gene function in hematopoietic, breast and lung carcinogenesis. Anticancer Res 2003; 23: 210110.
  • 33
    Guo M,Li J,Wan DGu J. KIAA0101 (OEACT-1), an expressionally down-regulated and growth-inhibitory gene in human hepatocellular carcinoma. BMC Cancer 2006; 6: 109.
  • 34
    Mizutani K,Onda M,Asaka S,Akaishi J,Miyamoto S,Yoshida A,Nagahama M,Ito K,Emi M. Overexpressed in anaplastic thyroid carcinoma-1 (OEATC-1) as a novel gene responsible for anaplastic thyroid carcinoma. Cancer 2005; 103: 178590.
  • 35
    Hosokawa M,Takehara A,Matsuda K,Eguchi H,Ohigashi H,Ishikawa O,Shinomura Y,Imai K,Nakamura Y,Nakagawa H. Oncogenic role of KIAA0101 interacting with proliferating cell nuclear antigen in pancreatic cancer. Cancer Res 2007; 67: 256876.
  • 36
    Scrideli CA,Carlotti CGJr,Mata JF,Neder L,Machado HR,Oba-Sinjo SM,Rosemberg S,Marie SK,Tone LG. Prognostic significance of co-overexpression of the EGFR/IGFBP-2/HIF-2A genes in astrocytomas. J Neurooncol 2007; 83: 2339.
  • 37
    Verlinden L,Eelen G,Beullens I,Van Camp M,Van Hummelen P,Engelen K,Van Hellemont R,Marchal K,De Moor B,Foijer F,Te Riele H,Beullens M, et al. Characterization of the condensin component Cnap1 and protein kinase Melk as novel E2F target genes down-regulated by 1,25-dihydroxyvitamin D3. J Biol Chem 2005; 280: 3731930.
  • 38
    Seong HA,Gil M,Kim KT,Kim SJHa H. Phosphorylation of a novel zinc-finger-like protein, ZPR9, by murine protein serine/threonine kinase 38 (MPK38). Biochem J 2002; 361 (Part 3): 597604.
  • 39
    Seong HA,Kim KT,Ha H. Enhancement of B-MYB transcriptional activity by ZPR9, a novel zinc finger protein. J Biol Chem 2003; 278: 965562.
  • 40
    Lin ML,Park JH,Nishidate T,Nakamura YKatagiri T. Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family. Breast Cancer Res 2007; 9: R17.
  • 41
    Vulsteke V,Beullens M,Boudrez A,Keppens S,Van Eynde A,Rider MH,Stalmans W,Bollen M. Inhibition of spliceosome assembly by the cell cycle-regulated protein kinase MELK and involvement of splicing factor NIPP1. J Biol Chem 2004; 279: 86427.
  • 42
    Davezac N,Baldin V,Blot J,Ducommun B,Tassan JP. Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase: a potential role for pEg3 in cell cycle regulation. Oncogene 2002; 21: 763041.
  • 43
    Fournier MV,Martin KJ,Kenny PA,Xhaja K,Bosch I,Yaswen P,Bissell MJ. Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer. Cancer Res 2006; 66: 7095102.
  • 44
    Badouel C,Korner R,Frank-Vaillant M,Couturier A,Nigg EA,Tassan JP. M-phase MELK activity is regulated by MPF and MAPK. Cell Cycle 2006; 5: 8839.
  • 45
    Easterday MC,Dougherty JD,Jackson RL,Ou J,Nakano I,Paucar AA,Roobini B,Dianati M,Irvin DK,Weissman IL,Terskikh AV,Geschwind DH, et al. Neural progenitor genes. Germinal zone expression and analysis of genetic overlap in stem cell populations. Dev Biol 2003; 264: 30922.
  • 46
    Okamoto OK,Oba-Shinjo SM,Lopes L,Nagahashi Marie SK. Expression of HOXC9 and E2F2 are up-regulated in CD133+ cells isolated from human astrocytomas and associate with transformation of human astrocytes. Biochim Biophys Acta 2007; 1769: 43742.
  • 47
    Liu G,Yuan X,Zeng Z,Tunici P,Ng H,Abdulkadir IR,Lu L,Irvin D,Black KLYu JS. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006; 5: 67.